Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
Key facts
- Where
- Chokwé, MozambikSee the site
Where in Mozambik
- Hospital CarmeloChokwé, MozambikTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Trial code
- NCT06607588
- Record updated
- 2025. május 15.
- Original description
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.Read full original descriptionShow less
Selection of Resistant Mutations to Dolutegravir and Associated Drugs in PLWH Treated in Clinical Practice in Chokwé, Mozambique
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.
Inclusion: Patients able to understand and sign the informed consent form; Documented HIV-1 infection; Under the first line TLD for at least 6 months; At least 3 months follow-up with CV \>200c/ml.
Exclusion: Patients with active opportunistic diseases; Patients \<18 years of age; Under the first line regime other than TLD; Patients with active neoplastic processes; Patients unable to give informed consent.